#$%^&*AU2020223706A120200910.pdf#####ABSTRACT The present invention provides compositions and methods of treating and improving the symptoms of rheumatoid arthritis using an antibody that specifically binds human 5 interleukin-6 receptor (hlL-6R). 15807467_1 (GHMatters) P41827AU01